Target intelligence / Profile preview

Ribosomal protein L36a pseudogene 18 (RPL36AP18)

Target
RPL36AP18
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L36a pseudogene 18 (RPL36AP18) is a processed pseudogene in the human genome[10]. It shares high sequence similarity with the protein-coding gene ribosomal protein L36a (RPL36A), which encodes a structural component of the 60S ribosomal subunit[3][7][10]. However, RPL36AP18 does not encode a functional protein[10]. Like many pseudogenes, it is unlikely to possess significant biological or therapeutic relevance. It is not considered a drug target, nor does it participate in known cellular pathways, molecular functions, or disease processes[10]. Key context: - Pseudogenes such as RPL36AP18 arise from gene duplication or retrotransposition events involving functional genes (here, RPL36A), but they typically accumulate mutations rendering them nonfunctional[3][10]. - While some pseudogenes may exert regulatory roles at the RNA level in rare cases, there is no evidence that RPL36AP18 is functional or relevant in molecular pharmacology or therapeutics[10]. This entry should *not* be treated as a valid therapeutic target in drug discovery or biomedical research contexts.

Other names
RPL36A_5_491RPL36AP18

Beyond the preview

Go deeper on Ribosomal protein L36a pseudogene 18 (RPL36AP18).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L36a pseudogene 18 (RPL36AP18).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call